ET-01 in Subjects With Lateral Canthal Lines, LCL-210

Status Active, not recruiting

Clinical Trial Summary

This study tests an investigational drug formulation called ET-01, botulinum toxin, Type A, topical, in lateral canthal lines (LCL).

Clinical Trial Description

This product is being tested for its ability to reduce lateral canthal lines (LCL), also known as Crow's Feet. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04985916
Study type	Interventional
Source	Eirion Therapeutics Inc.
Contact
Status	Active, not recruiting
Phase	Phase 2
Start date	July 19, 2021
Completion date	April 2024

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01951742` - Dose Finding Study In Subjects With Crow's Feet	Phase 2
Completed	`NCT03326856` - ET-01 in Subjects With Lateral Canthal Lines	Phase 2
Completed	`NCT03839693` - ET-01 in Subjects With Lateral Canthal Lines, LCL-208	Phase 2
Completed	`NCT00888914` - Safety and Efficacy Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines	Phase 2
Active, not recruiting	`NCT06021418` - Efficacy and Safety of DKB-119 in Patients in Crow's Feet	N/A
Completed	`NCT01358695` - Clinical Trial To Evaluate ANT-1207 In Subjects With Crow's Feet	Phase 2
Completed	`NCT01124565` - Safety Study of Two Repeat Doses of RT001 for the Treatment of Moderate to Severe Lateral Canthal Lines in Adults	Phase 2
Completed	`NCT00968825` - Safety and Efficacy Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines	Phase 2
Recruiting	`NCT04818203` - A Study on the Anti-Wrinkle Efficacy Assessment and Safety Evaluation of the Cluster of Autologous Dermal Fibroblast on Bilateral Crow's Feet	Phase 1/Phase 2
Completed	`NCT01064518` - Efficacy and Safety Study of RT001 for the Treatment of Moderate to Severe Lateral Canthal Lines in Adults	Phase 2
Completed	`NCT03912805` - ET-01 in Subjects With Lateral Canthal Lines, LCL-209	Phase 2
Completed	`NCT00968942` - Efficacy and Safety Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines	Phase 2
Completed	`NCT03655691` - ET-01 in Subjects With Lateral Canthal Lines, LCL-207	Phase 2
Completed	`NCT01124552` - A 4-Arm Efficacy and Safety Study of RT001 for the Treatment of Moderate to Severe Lateral Canthal Lines in Adults	Phase 2